Reduced Dose of Prophylactic Dexamethasone for Elderly Patients Receiving Moderate Emetogenic Chemotherapy
Feasibility study to evaluate the efficacy of reduced prophylactic dose of dexamethasone in elderly patients receiving moderate emetogenic chemotherapy
Colonic Neoplasms
DRUG: Dexamethasone
Complete response (CR), No emetic episode, no rescue medicine, 2 weeks
Complete control (CC), complete response with no more than mild nausea, 2 weeks|Complete protection (CP), complete response with no nausea, 2 weeks
The purpose of this trial is to determine if the dose of dexamethasone used as an antiemetic drug in patients with advanced cancer could be safely reduced.